Discover a standardized approach to validating high-parameter spectral flow cytometry assays for reliable immune monitoring in clinical research.

This scientific poster highlights the development and validation of a 26-color spectral flow cytometry assay designed in alignment with CLSI H62 recommendations. The study demonstrates analytical performance across a broad range of immune cell populations by evaluating assay precision, reproducibility, stability, and sensitivity to support standardized immunophenotyping in regulated clinical studies.

Key highlights include:

• Validation of a 26-color spectral flow cytometry assay using CLSI H62 guidance
• Assessment of assay precision and reproducibility through a structured factorial study design
• Evaluation of rare and low-frequency immune cell population detection
• Stability testing of whole blood and fixed specimens under clinically relevant conditions
• A standardized framework for high-dimensional immune profiling in clinical research

Learn how a validated, standardized spectral flow cytometry assay can support consistent immune monitoring, improve data quality, and enable comprehensive characterization of immune cell populations throughout clinical development.